Biopsafe ApS: Financial statements 2015
CVR: 33575505
Source: annual report 2015, Danish Business Authority
01/04/2014 – 31/03/2015
Biopsafe ApS (CVR 33575505) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 265,538 and a net result of DKK -1,005,650 compared with DKK -222,019 the year before. Equity in the 2015 report amounted to DKK 140,061. The solvency ratio was 0.8%.
- Gross Profit
- DKK 265,538
- Profit/Loss
- DKK -1,005,650
- Equity
- DKK 140,061
- Total Assets
- DKK 16,890,322
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 266 t. | -1 mio. | 140 t. | - |
| 2014 | - | -2 | -222 t. | 111 t. | - |
| 2013 | - | 0 | -43 t. | 83 t. | - |
Official annual report
How creditworthy is Biopsafe ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Biopsafe ApS
Biopsafe ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2011. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named AX-LAB INNOVATION ApS. The management consists of Anne Lykke Gade. The board consists of Anders Dahlberg. The company is owned by MedCap AB (publ). The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 14,274,000 and a net result of DKK 6,231,000 compared with DKK 4,087,000 the year before. Equity in the 2025 report amounted to DKK 11,231,000.